RA

Active Director Additional Director DIN 02770043
DIN 02770043 First appointment Nov 2008 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 4 active board seats
Past companies 9 historical roles
Total affiliations 13 Since Nov 2008
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 01 Nov 2008
Active appointments 9
Total timeline records 13

Rifat Ali (DIN 02770043) has 13 recorded board appointments in Indian companies, the first from November 2008, of which 9 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2008
Euphoria Food & Beverages Private Limited Director · 2014 – present
Current
Astin Pharmaceuticals Private Limited Additional Director · 2013 – present
Current
Sanador International Hospitality Private Limited Additional Director · 2013 – present
Current
Krishna Medpharma Private Limited Additional Director · 2013 – present
Current
Health India Broadcast Private Limited Director · 2012 – present
Current
Rapid Drugs Private Limited Director · 2012 – present
Current
Rapid Hospitals Private Limited Director · 2012 – present
Current
Krishna Medtraders Private Limited Director · 2012 – present
Current
Luv Kush Medicare Private Limited Director · 2010 – present
Current
Rapid Continental Expo Private Limited Additional Director · 2012 – 2013
Previous
Smith And Sapphire Bio-Tech Limited Additional Director · 2011 – 2012
Previous
Shirdi Sai India Multiple Business Private Limited Additional Director · 2009 – 2012
Previous
S P C Remedies Private Limited Director · 2008 – 2012
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available